Vaccinex (VCNX) Tops Q1 EPS by 20c

Vaccinex (NASDAQ: VCNX) reported Q1 EPS of ($0.10), $0.20 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $550 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Robinhood prices $2B convertible notes offering due 2029